Document Detail


Posaconazole for chronic pulmonary aspergillosis: the next strategy against the threat of azole-resistant Aspergillus infection.
MedLine Citation:
PMID:  21054178     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
Shigeru Kohno; Koichi Izumikawa
Related Documents :
24614368 - Inhibition of cellular v-atpase impairs human papillomavirus uncoating and infection.
23221198 - Central line-associated bloodstream infections in adult hematology patients with febril...
24487048 - Pediatric microbial keratitis in taiwan: clinical and microbiological profiles, 1998-20...
24447798 - Dirofilaria repens infection in a dog imported to norway.
3721358 - The response of captive rodents to the migration of ancylostoma caninum larvae.
21870348 - Streptococcus equi subspecies equi infection (strangles) in horses.
Publication Detail:
Type:  Comment; Editorial     Date:  2010-11-05
Journal Detail:
Title:  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America     Volume:  51     ISSN:  1537-6591     ISO Abbreviation:  Clin. Infect. Dis.     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-18     Completed Date:  2011-02-25     Revised Date:  2013-11-25    
Medline Journal Info:
Nlm Unique ID:  9203213     Medline TA:  Clin Infect Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1392-4     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antifungal Agents / therapeutic use*
Aspergillus / drug effects*
Drug Resistance, Fungal*
Humans
Pulmonary Aspergillosis / drug therapy*
Treatment Outcome
Triazoles / therapeutic use*
Chemical
Reg. No./Substance:
0/Antifungal Agents; 0/Triazoles; 6TK1G07BHZ/posaconazole
Comments/Corrections
Comment On:
Clin Infect Dis. 2010 Dec 15;51(12):1383-91   [PMID:  21054179 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Rearrest after prehospital resuscitation.
Next Document:  Efficacy and safety of posaconazole for chronic pulmonary aspergillosis.